Grant-Huerta Yanina
SEC insider (Form 3/4/5 filer). CIK 0002064348. Chief Financial Officer at ImageneBio, Inc. (IMA) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in SAN DIEGO, CA.
Companies Grant-Huerta Yanina has filed insider reports for
- ImageneBio, Inc. (IMA): Officer, Chief Financial Officer
- Atara Biotherapeutics, Inc. (ATRA): Officer, Chief Accounting Officer
Grant-Huerta Yanina
CIK: 0002064348
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Aug 14, 2026IMA
ImageneBio, Inc.
AwardDirect39K shares- - Aug 14, 2026IMA
ImageneBio, Inc.
AwardDirect65K shares- - May 18, 2026ATRA
Atara Biotherapeutics, Inc.
SaleDirect2.4K shares at avg. $9.13$22K - Mar 9, 2026ATRA
Atara Biotherapeutics, Inc.
AwardDirect20.3K shares- - Mar 2, 2026ATRA
Atara Biotherapeutics, Inc.
SaleDirect24 shares at avg. $5.08$121.848 - Mar 2, 2026ATRA
Atara Biotherapeutics, Inc.
SaleDirect1.6K shares at avg. $5.08$8K - Mar 2, 2026ATRA
Atara Biotherapeutics, Inc.
SaleDirect377 shares at avg. $5.08$2K - Mar 2, 2026ATRA
Atara Biotherapeutics, Inc.
SaleDirect100 shares at avg. $5.08$508.3 - Nov 17, 2025ATRA
Atara Biotherapeutics, Inc.
SaleDirect1.6K shares at avg. $13.19$22K - Nov 17, 2025ATRA
Atara Biotherapeutics, Inc.
SaleDirect85 shares at avg. $13.19$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 |  IMA ImageneBio, Inc. | Award | 39,000 | - | $0 | Direct |
| Aug 14, 2026 | IMA ImageneBio, Inc. | Award | 65,000 | - | $0 | Direct |
| May 18, 2026 |  ATRA Atara Biotherapeutics, Inc. | Sale | 2,414 | $9.13 | $22,036 | Direct |
| Mar 9, 2026 | ATRA Atara Biotherapeutics, Inc. | Award | 20,300 | - | $0 | Direct |
| Mar 2, 2026 | ATRA Atara Biotherapeutics, Inc. | Sale | 24 | $5.08 | $122 | Direct |
| Mar 2, 2026 | ATRA Atara Biotherapeutics, Inc. | Sale | 1,603 | $5.08 | $8,145 | Direct |
| Mar 2, 2026 | ATRA Atara Biotherapeutics, Inc. | Sale | 377 | $5.08 | $1,916 | Direct |
| Mar 2, 2026 | ATRA Atara Biotherapeutics, Inc. | Sale | 100 | $5.08 | $508 | Direct |
| Nov 17, 2025 | ATRA Atara Biotherapeutics, Inc. | Sale | 1,645 | $13.19 | $21,691 | Direct |
| Nov 17, 2025 | ATRA Atara Biotherapeutics, Inc. | Sale | 85 | $13.19 | $1,121 | Direct |
1-10 of 15 transactions